Antibiotic resistance characteristics and risk factors analysis of

Yanmeng Wang, Yiling Li, Yuehua Gong, Yuzhen Dong, Jing Sun, Moye Chen

Abstract read

In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

Comparison of Keverprazan-based versus esomeprazole-based dual therapy for initial treatment ofAnnals of medicine · 2026
Trial
A Modified 14-Day Dual Therapy with Vonoprazan and Amoxicillin Amplified the Advantages Over Conventional Therapies for Eradication ofInfection and drug resistance · 2023
Trial
Success of susceptibility-guided eradication ofWorld journal of gastroenterology · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yanmeng WangGastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Yiling LiGastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Yuehua GongKey Laboratory of GI Cancer Etiology and Prevention, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Yuzhen DongGastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Jing SunGastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Moye ChenGastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prevalence of Methods: Gastric tissues from 178 Results: No resistance was observed in AOZ or TC. For LFX, MET, CLA, and AMX, the overall resistance rates were 41.10%, 79.14%, 71.78%, and 22.09% respectively. There were significant differences between resistance to CLA and MALToma ( Conclusions: The primary resistant rates of LEX, MET, CLA, and AMX were relatively high in Liaoning. Treatment effectiveness improvement could be achieved by prior antimicrobial susceptibility tests before antibiotic prescription.

Indexed as

Helicobacter InfectionsHelicobacter pyloriAmoxicillinAnti-Bacterial AgentsChinaClarithromycinDrug Resistance, BacterialHumansLevofloxacinMetronidazoleRisk FactorsTetracyclineAmoxicillinAnti-Bacterial AgentsClarithromycinLevofloxacinMetronidazoleTetracyclineAntibiotic resistanceEradicationHelicobacter pyloriLiaoning ProvinceMulti-resistanceRegional characteristic

Identifiers

PMID37214095

DOI10.7717/peerj.15268

PMCPMC10198150

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.